Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;83(3):381-412.
doi: 10.1016/j.jinf.2021.05.035. Epub 2021 May 29.

Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination

Rachael Kathleen Raw  1 , Clive Anthony Kelly  2 , Jon Rees  3 , Caroline Wroe  2 , David Robert Chadwick  2
Affiliations
Comment

Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination

Rachael Kathleen Raw et al. J Infect. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations of Competing Interest No conflicts of interest.

Figures

Fig. 1
Fig. 1
Moderate and Severe Symptoms by COVID-19 Status: Percentage of cases reporting moderate or severe symptoms (95% CI) in those with and without a history of COVID-19 (the former including Long-COVID). N & V: nausea and vomiting. Upper panel (A): entire cohort; lower panel (B): sensitivity analysis subset.
See this image and copyright information in PMC

Comment on

References

    1. Tré-Hardy M., Cupaiolo R., Papleux E., et al. Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers. J Infect. 2021 doi: 10.1016/j.jinf.2021.03.025. Article in press. - DOI - PMC - PubMed
    1. Krammer F., Srivastava K., Marks F., et al. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a 1 single dose of SARS-CoV-2 mRNA vaccine. MedRxiv. 2021 doi: 10.1101/2021.01.29.21250653. 2021.01.29.21250653. - DOI
    1. Kings College London COVID Symptom Study. Here's what we know so far about the after effects of the Pfizer COVID vaccine. 2021. https://covid.joinzoe.com/post/covid-vaccine-pfizer-effects (accessed Feb 5, 2021).
    1. Mathioudakis A.G., Ghrew M., Ustianowski A. et al. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: an international vaccine-recipient survey. MedRxiv 2021; 2021.02.26.21252096. doi: 10.1101/2021.02.26.21252096. - PMC - PubMed
    1. Carfì A., Bernabei R., Landi F. Gemelli against COVID-19 post-acute care study group. persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. doi: 10.1001/jama.2020.12603. - DOI - PMC - PubMed